Related references
Note: Only part of the references are listed.To pill or not to pill in GnRH antagonist cycles: that is the question!
Juan A. Garcia-Velasco et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2015)
Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection
Asia Asiaf et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2014)
Pharmacokinetic evaluation of desogestrel as a female contraceptive
Giovanni Grandi et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Epidemiology, diagnosis, and management of polycystic ovary syndrome
Susan M. Sirmans et al.
CLINICAL EPIDEMIOLOGY (2014)
Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks
Jan Brynhildsen
THERAPEUTIC ADVANCES IN DRUG SAFETY (2014)
History of oral contraceptive drugs and their use worldwide
Sophie Christin-Maitre
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review
Jennifer M. Gierisch et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism
Vincenzo De Leo et al.
CONTRACEPTION (2013)
Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis
Bernardine H. Stegeman et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
PMS as a process of negotiation: Women's experience and management of premenstrual distress
Jane M. Ussher et al.
PSYCHOLOGY & HEALTH (2013)
Premenstrual Dysphoric Disorder: Evidence for a New Category for DSM-5
C. Neill Epperson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Low-dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence
David Cibula et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
The Epidemiology of Endometrial and Ovarian Cancer
Daniel W. Cramer
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2012)
Screening Women for Oral Contraception Can Family History Identify Inherited Thrombophilias?
David A. Grimes et al.
OBSTETRICS AND GYNECOLOGY (2012)
Risk factors for venous thromboembolism in pre- and postmenopausal women
Annica Bergendal et al.
THROMBOSIS RESEARCH (2012)
Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study
Naomi Gronich et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2011)
Antiadipogenic Effects of the Mineralocorticoid Receptor Antagonist Drospirenone: Potential Implications for the Treatment of Metabolic Syndrome
Massimiliano Caprio et al.
ENDOCRINOLOGY (2011)
Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes?
Anne Guivarc'h-Leveque et al.
FERTILITY AND STERILITY (2011)
Combined oral contraceptives in women with menstrual migraine without aura
Vincenzo De Leo et al.
FERTILITY AND STERILITY (2011)
Hormonal Contraceptives and the Length of Their Use Are Not Independent Risk Factors for High-Risk HPV Infections or High-Grade CIN
Adhemar Longatto-Filho et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2011)
The FIGO Recommendations on Terminologies and Definitions for Normal and Abnormal Uterine Bleeding
Ian S. Fraser et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2011)
Estradiol valerate and dienogest: a novel four-phasic oral contraceptive pill effective for pregnancy prevention and treatment of heavy menstrual bleeding
Elizabeth Micks et al.
WOMENS HEALTH (2011)
Review of clinical experience with estradiol in combined oral contraceptives
Franca Fruzzetti et al.
CONTRACEPTION (2010)
Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome
Vincenzo De Leo et al.
CONTRACEPTION (2010)
Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): A Phase III trial
Santiago Palacios et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2010)
Low-dose Oral Contraceptives in Adolescents: How Low Can You Go?
H. Agostino et al.
JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY (2010)
Recent Innovations in Oral Contraception
Miriam Cremer et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2010)
Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study
Juergen Dinger et al.
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE (2010)
Spatiotemporal electromyography during human labor to monitor propagation of the uterine contraction wave and diagnose dystocia
Catalin S. Buhimschi
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial
Angelo Cagnacci et al.
CONTRACEPTION (2009)
Contraceptive considerations in obese women
[Anonymous]
CONTRACEPTION (2009)
Estradiol Valerate/Dienogest In Oral Contraception
Sheridan M. Hoy et al.
DRUGS (2009)
Contraceptive Hormone Use and Cardiovascular Disease
Chrisandra L. Shufelt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Early Weight Gain Predicting Later Weight Gain Among Depot Medroxyprogesterone Acetate Users
Yen-Chi L. Le et al.
OBSTETRICS AND GYNECOLOGY (2009)
Reproductive History, Oral Contraceptive Use, and the Risk of Ischemic and Hemorrhagic Stoke in a Cohort Study of Middle-Aged Swedish Women
Ling Yang et al.
STROKE (2009)
Migraine and cardiovascular disease: systematic review and meta-analysis
Markus Schuerks et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Contraception for women: an evidence based overview
Jean-Jacques Amy et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Continuous oral contraception: changing times
Patricia J. Sulak
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2008)
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies
Jan Endrikat et al.
CONTRACEPTION (2008)
Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis
George Griesinger et al.
FERTILITY AND STERILITY (2008)
Oral contraceptives in polycystic ovary syndrome: Risk-benefit assessment
Bulent O. Yildiz
SEMINARS IN REPRODUCTIVE MEDICINE (2008)
Cervical cancer and hormonal contraceptives:: Collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies
Paul Appleby et al.
LANCET (2007)
A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women
Karen L. Margolis et al.
FERTILITY AND STERILITY (2007)
Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome
Vincenzo De Leo et al.
FERTILITY AND STERILITY (2007)
The oral contraceptive containing 30 μg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle:: an observational study
Franca Fruzzetti et al.
CONTRACEPTION (2007)
Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis
S. Nader et al.
HUMAN REPRODUCTION (2007)
Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 mu g (Loestrin (R) 24 Fe)
Steven T. Nakajima et al.
CONTRACEPTION (2007)
Nutrition and reproduction in women
DT Baird et al.
HUMAN REPRODUCTION UPDATE (2006)
Contraception in perimenopausal women with diabetes mellitus
Olga R. Grigoryan et al.
GYNECOLOGICAL ENDOCRINOLOGY (2006)
Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception
MK Clark et al.
INTERNATIONAL JOURNAL OF OBESITY (2005)
Pharmacology of estrogens and progestogens: influence of different routes of administration
H Kuhl
CLIMACTERIC (2005)
Combined oral contraceptives in the treatment of polycystic ovary syndrome
J Vrbíková et al.
HUMAN REPRODUCTION UPDATE (2005)
Combination estrogen-progestin contraceptives and body weight: Systematic review of randomized controlled trials
MF Gallo et al.
OBSTETRICS AND GYNECOLOGY (2004)
Conception and pharmacodynamic profile of drospirenone
W Elger et al.
STEROIDS (2003)
A multicenter, randomized study of an extended cycle oral contraceptive
FD Anderson et al.
CONTRACEPTION (2003)
Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial
M Kwiecien et al.
CONTRACEPTION (2003)
Progestogens with antiandrogenic properties
D Raudrant et al.
DRUGS (2003)
To what extent do oral contraceptives influence mood and affect?
KA Oinonen et al.
JOURNAL OF AFFECTIVE DISORDERS (2002)
Methodological quality of WHO medical eligibility criteria for contraceptive use
J Stanback et al.
CONTRACEPTION (2002)
Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study
K Elter et al.
HUMAN REPRODUCTION (2002)
Oral contraceptives and the risk of breast cancer
PA Marchbanks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms
PJ Sulak et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2002)
Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection:: the IARC multicentric case-control study
V Moreno et al.
LANCET (2002)
Oral contraceptive use in perimenopause
AM Kaunitz
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2001)
A 12-month clinical investigation with a 24-day regimen containing 15 μg ethinylestradiol plus 60 μg gestodene with respect to hemostasis and cycle control
F Fruzzetti et al.
CONTRACEPTION (2001)
The emerging use of the 20-μg oral contraceptive
A Poindexter
FERTILITY AND STERILITY (2001)
Role of hormones in pilosebaceous unit development
D Deplewski et al.
ENDOCRINE REVIEWS (2000)
Changes in the distribution of body mass index of adults and children in the US population
KM Flegal et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
Maternal age and fetal loss: population based register Linkage study
AMN Andersen et al.
BRITISH MEDICAL JOURNAL (2000)
Hormone withdrawal symptoms in oral contraceptive users
PJ Sulak et al.
OBSTETRICS AND GYNECOLOGY (2000)
Oral contraceptives and bone mineral density: A population-based study
JA Pasco et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2000)
Share Paper
